Clovis Oncology, Inc. (CLVS): Price and Financial Metrics
CLVS Price/Volume Stats
| Current price | $0.08 | 52-week high | $3.32 |
| Prev. close | $0.09 | 52-week low | $0.08 |
| Day low | $0.08 | Volume | 24,516,400 |
| Day high | $0.10 | Avg. volume | 8,875,886 |
| 50-day MA | $0.59 | Dividend yield | N/A |
| 200-day MA | $1.29 | Market Cap | 11.77M |
CLVS Stock Price Chart Interactive Chart >
Clovis Oncology, Inc. (CLVS) Company Bio
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. The company was founded in 2009 and is based in Boulder, Colorado.
CLVS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -97.44% |
| 5-year | -99.08% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -43.54% |
| 2020 | -53.96% |
| 2019 | -41.95% |
Continue Researching CLVS
Here are a few links from around the web to help you further your research on Clovis Oncology Inc's stock as an investment opportunity:Clovis Oncology Inc (CLVS) Stock Price | Nasdaq
Clovis Oncology Inc (CLVS) Stock Quote, History and News - Yahoo Finance
Clovis Oncology Inc (CLVS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...